Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,129 public trials 1,864 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Recruiting

A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy

NCT07564401

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer (ES-SCLC), +8 more
Locations
  • University of Kentucky Lexington, Kentucky, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
  • Novartis Investigative Site Singapore
View Trial Details
Recruiting

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

NCT07227298

Conditions
Advanced/Metastatic Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
  • Highlands Oncology Group, PA Rogers, Arkansas, United States
  • Highlands Oncology Group, PA Springdale, Arkansas, United States
  • Providence Medical Foundation Fullerton, California, United States
View all 87 locations
View Trial Details
Recruiting

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

NCT06312137

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
Locations
  • UAMS Winthrop P. Rockefeller Cancer Institute ( Site 0060) Little Rock, Arkansas, United States
  • Highlands Oncology Group-Research Department ( Site 0062) Springdale, Arkansas, United States
  • Beverly Hills Cancer Center ( Site 0070) Beverly Hills, California, United States
  • The Angeles Clinic and Research Institute ( Site 0040) Los Angeles, California, United States
View all 268 locations
View Trial Details
Recruiting

A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice

NCT07284121

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations
  • Landesklinikum Krems Krems, Austria
  • Ordensklinikum Linz Elisabethinen Linz, Austria
  • Krankenhaus Nord - Klinik Floridsdorf Vienna, Austria
  • Klinikum Wels-Grieskirchen Wels, Austria
View all 92 locations
View Trial Details
Recruiting

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

NCT06772623

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic Hospital - Phoenix /ID# 272971 Phoenix, Arizona, United States
  • Providence - St. Jude Medical Center /ID# 271414 Fullerton, California, United States
  • FOMAT Medical Research - Clinica mi Salud by Focil Med /ID# 274450 Oxnard, California, United States
  • UCLA - Santa Monica /ID# 271690 Santa Monica, California, United States
View all 121 locations
View Trial Details
Recruiting

A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

NCT06646276

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer, +8 more
Locations
  • Southern Cancer Center, PC Daphne, Alabama, United States
  • Local Institution - 0283 Hot Springs, Arkansas, United States
  • Florida Cancer Specialists - South Fort Myers, Florida, United States
  • Mid Florida Hematology and Oncology Center Orange City, Florida, United States
View all 183 locations
View Trial Details
Recruiting

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

NCT06303505

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +22 more
Locations
  • The University of Alabama Birmingham, Alabama, United States
  • Mount Sinai New York, United States
  • Christ Hospital Cincinnati, Ohio, United States
  • Ohio State University Columbus, Ohio, United States
View all 29 locations
View Trial Details
Recruiting

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

NCT07388524

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Helen F Graham Cancer Center Newark, Delaware, United States
  • Medical Oncology Hematology Consultants PA Newark, Delaware, United States
  • Kootenai Health - Coeur d'Alene Coeur d'Alene, Idaho, United States
  • Kootenai Clinic Cancer Services - Post Falls Post Falls, Idaho, United States
View all 63 locations
View Trial Details

Related conditions